Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile

ConclusionsMSCs are a promising therapy for BPD, but they should be administered in early stages of the disease.
Source: Cytotherapy - Category: Cytology Source Type: research